ResMed Balance Sheet
RMD / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
ResMed had $8.2B in total assets and $6.0B in shareholders' equity as of FY2025. Total debt was $658M against $1.2B in cash, resulting in a $551M net cash position.
Based on SEC 10-K filings.
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.2B | $238.4M | $227.9M | $273.7M | $295.3M | $463.2M | $147.1M | $188.7M | $821.9M | $731.4M | $717.2M | $905.7M | $876.0M | $809.5M | $735.3M |
| Accounts Receivable | $939.5M | $837.3M | $704.9M | $576.0M | $614.3M | $474.6M | $528.5M | $483.7M | $450.5M | $382.1M | $362.6M | $359.6M | $318.3M | - | - |
| Inventory | $927.7M | $822.3M | $998.0M | $743.9M | $457.0M | $416.9M | $349.6M | $268.7M | $268.3M | $224.5M | $246.9M | $165.4M | $145.8M | $174.4M | $200.8M |
| Current Assets | $3.5B | $2.4B | $2.4B | $1.9B | $1.6B | $1.5B | $1.1B | $1.1B | $1.6B | $1.4B | $1.4B | $1.6B | $1.4B | $1.4B | $1.3B |
| PP&E (Net) | $550.8M | $548.0M | $537.9M | $498.2M | $463.5M | $417.3M | $387.5M | $386.6M | $394.2M | $384.3M | $387.8M | $434.3M | $411.4M | $434.4M | $462.1M |
| Goodwill | $3.0B | $2.8B | $2.8B | $1.9B | $1.9B | $1.9B | $1.9B | $1.1B | $1.1B | $1.1B | $264.3M | $289.3M | $274.8M | $256.2M | $235.5M |
| Total Assets | $8.2B | $6.9B | $6.8B | $5.1B | $4.7B | $4.6B | $4.1B | $3.1B | $3.5B | $3.3B | $2.2B | $2.4B | $2.2B | $2.1B | $2.1B |
| Current Liabilities | $1.0B | $910.7M | $758.5M | $689.3M | $911.8M | $602.8M | $556.0M | $511.2M | $360.1M | $638.0M | $266.5M | $269.6M | $574.0M | $252.9M | $208.8M |
| Total Debt | $658.4M | $697.3M | $1.4B | $765.3M | $643.4M | $1.2B | $1.3B | $270.0M | $1.1B | $873.3M | $300.6M | $300.8M | $300.8M | $250.8M | $100.2M |
| Shareholders' Equity | $6.0B | $4.9B | $4.1B | $3.4B | $2.9B | $2.5B | $2.1B | $2.1B | $2.0B | $1.7B | $1.6B | $1.8B | $1.6B | $1.6B | $1.7B |